ARIADPharmaceuticals

ARIADPharmaceuticals

ARIADPharmaceuticals

ARIAD Pharmaceuticals ($ARIA) is focused on medicines to transform the lives of cancer patients. Read our twitter policy on our site
Founded
1991
Follow us
Alexa global traffic share
Twitter followers
Acquired by
Takeda
1
09 Jan 2017
$5,200,000,000
$5,200,000,000
Xconomy

Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio

Health Strategy
The Motley Fool

Why Ariad Pharmaceuticals, Nevsun Resources, and Ctrip.com International Slumped Today

Stock markets Earnings Health
The Motley Fool

Is It Time to Buy Ariad Pharmaceuticals' Stock?

Health Stock markets
The Motley Fool

3 Charts Show Why Buying Ariad Pharmaceuticals May Be Risky

Earnings Health Stock markets
The Motley Fool

Why Ariad Pharmaceuticals Shares Jumped 11.2% In February

Earnings Health Stock markets